Concepedia

S. Modi

SM

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2025

Affiliations

Cancer Trials Ireland(Current)

S. Modi is an author at Cancer Trials Ireland specializing in pertuzumab therapy, immunotherapy, and neoadjuvant therapy.

Publications per year

2025–2025

1

Publications

1

291O DESTINY-Breast11: Neoadjuvant trastuzumab deruxtecan alone (T-DXd) or followed by paclitaxel + trastuzumab + pertuzumab (T-DXd-THP) vs SOC for high-risk HER2+ early breast cancer (eBC)

N. Harbeck, S. Modi, L. Pusztai et al. · Annals of Oncology · 2025 · 12 citations

, , +14

1–1 of 1